Filing Details

Accession Number:
0001209191-19-034560
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-06-04 19:07:33
Reporting Period:
2019-06-02
Accepted Time:
2019-06-04 19:07:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1029142 Dynavax Technologies Corp DVAX Pharmaceutical Preparations (2834) 330728374
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1278710 Robert Coffman C/O Dynavax Technologies
2929 Seventh Street, Suite 100
Berkeley CA 94710
Senior Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-06-02 54,702 $0.00 132,470 No 4 M Direct
Common Stock Disposition 2019-06-04 22,484 $4.58 109,986 No 4 F Direct
Common Stock Disposition 2019-06-04 32,218 $4.58 77,768 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock unit Disposition 2019-06-02 54,702 $0.00 54,702 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
Footnotes
  1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock. The RSUs vest over two years with 50% vesting on each annual anniversary of June 2, 2017.
  2. The reporting person is reporting the withholding by Dynavax Technologies Corporation of 22,484 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on June 2, 2019.